Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00478101|
Recruitment Status : Completed
First Posted : May 24, 2007
Last Update Posted : March 13, 2008
For cancer patients with inadequate pain relief, a switch to an alternative opioid is the preferred option for symptomatic improvement. However, multiple opioids are often simultaneously administered for anecdotal reasons.
The present study isdesigned to assess the analgesic profiles of two different strategies in chronic cancer pain: the opioid rotation from oxycodone to transdermal fentanyl and the combination of oral oxycodone and transdermal fentanyl.
|Condition or disease||Intervention/treatment||Phase|
|Advanced Solid Cancers||Drug: oxycodone fentanyl||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||2006 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Study Start Date :||February 2006|
|Actual Study Completion Date :||April 2007|
- Change in pain score and treatment success
- Patient satisfaction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00478101
|Principal Investigator:||Se Hoon Park, MD||Gachon University Gil Medical Center, Incheon, Korea|